Guggenheim Capital’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Guggenheim Capital’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-30,529	Closed	-$638K	–	3080
2016 Q3	$638K	Buy	+30,529	New	+$352K	﹤0.01%	2288

Guggenheim Capital's VTAE Position: Q4 2016 in Review

Guggenheim Capital sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 30,529 shares — an estimated $638K sold.

Guggenheim Capital first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $638K in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Guggenheim Capital reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Guggenheim Capital sold 30,529 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $638K.
Guggenheim Capital first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
Guggenheim Capital's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $638K in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Guggenheim Capital's 13F filing for Q4 2016, filed 14 Feb 2017.